MicroRNA Expression Profiling and DNA Methylation Signature for Deregulated MicroRNA in Cutaneous T-Cell Lymphoma

Journal of Investigative Dermatology

Volumn 135, Issue 4, 2015, Pages 1128-1137

  Sandoval, Juan ^a   Díaz Lagares, Angel ^a   Salgado, Rocío ^b   Servitje, Octavio ^c   Climent, Fina ^c   Ortiz Romero, Pablo L ^d   Pérez Ferriols, Amparo ^e   Garcia Muret, Maria P ^f   Estrach, Teresa ^g   Garcia, Mar ^b   Nonell, Lara ^b   Esteller, Manel ^a,g,h   Pujol, Ramon M ⁱ   Espinet, Blanca ^b   Gallardo, Fernando ^b,i  

^a HOSPITAL DURAN I REYNALS   (Spain)

^b HOSPITAL DEL MAR   (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^d UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^e HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^f HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^g UNIVERSITY OF BARCELONA   (Spain)

^h INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

ⁱ UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD30 ANTIGEN; MICRORNA; MICRORNA 10B; MICRORNA 141; MICRORNA 142 3P 5P; MICRORNA 146A; MICRORNA 155; MICRORNA 181A; MICRORNA 181B; MICRORNA 193B; MICRORNA 200A; MICRORNA 200B; MICRORNA 200C; MICRORNA 21; MICRORNA 23B; MICRORNA 27B; MICRORNA 429; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER STAGING; CHEMICAL ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CPG ISLAND; CUTANEOUS T CELL LYMPHOMA; DNA METHYLATION; DOWN REGULATION; EPIGENETICS; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORK; GENETIC REGULATION; HUMAN; INFINIUM 450K ARRAY; INFLAMMATORY DERMATOSIS; LARGE CELL LYMPHOMA; MALE; MICROARRAY ANALYSIS; MYCOSIS FUNGOIDES; PRIORITY JOURNAL; PROMOTER REGION; SKIN DISEASE; UPREGULATION; VERY ELDERLY; CLINICAL TRIAL; CLUSTER ANALYSIS; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETICS; LYMPHOMATOID PAPULOSIS; LYMPHOPROLIFERATIVE DISEASE; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; RETROSPECTIVE STUDY; TUMOR CELL LINE; YOUNG ADULT;

ADULT; AGED; ANTIGENS, CD30; CELL LINE, TUMOR; CLUSTER ANALYSIS; CPG ISLANDS; DNA METHYLATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHOMA, T-CELL, CUTANEOUS; LYMPHOMATOID PAPULOSIS; LYMPHOPROLIFERATIVE DISORDERS; MALE; MICRORNAS; MIDDLE AGED; MYCOSIS FUNGOIDES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS, GENETIC; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84925385770     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2014.487     Document Type: Article

References (72)

1. Agar NS, Wedgeworth E, Crichton S et al. (2010) Survival outcomes and prognostic factors in mycosis fungoides/Sé zary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal. J Clin Oncol 28:4730-9
2. Allan RS, Nutt SL (2014) Deciphering the epigenetic code of T lymphocytes. Immunol Rev 261:50-61
3. Altorok N, Coit P, Hughes T et al. (2014) Genome-wide DNA methylation patterns in naive CD4+ T cells from patients with primary Sjögren's syndrome. Arthritis Rheumatol 66:731-9
4. Ballabio E, Mitchell T, van Kester MS et al. (2010) MicroRNA expression in Sezary syndrome: identification, function, and diagnostic potential. Blood 116:1105-13
5. Benner M, Ballabio E, van Kester M et al. (2012) Primary cutaneous anaplastic large cell lymphoma shows a distinct miRNA expression profile and reveals differences from tumor-stage mycosis fungoides. Exp Dermatol 21:630-42
6. Biagioni F, Bossel Ben-Moshe N, Fontemaggi G et al. (2012) miR-10b∗, a master inhibitor of the cell cycle, is down-regulated in human breast tumours. EMBO Mol Med 4:1214-29
7. Bibikova M, Barnes B, Tsan C et al. (2011) High density DNA methylation array with single CpG site resolution. Genomics 98:288-95
8. Calin CA, Croce CM (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6:857-66
9. Calin CA, Croce CM (2006b) MicroRNAs and chromosomal abnormalities in cancer cells. Oncogene 25:6202-10
10. Calin CA, Croce CM (2007) Chromosomal rearrangements and microRNAs: a new cancer link with clinical implications. J Clin Invest 117:2059-66
11. Chambwe N, Kormaksson M, Geng H et al. (2014) Variability in DNA methylation defines novel epigenetic subgroups of DLBCL associated with different clinical outcomes. Blood 123:1699-708
12. Chen J, Feilotter HE, Paré GC et al. (2010) MicroRNA-193b represses cell proliferation and regulates cyclin D1 in melanoma. Am J Pathol 176:2520-9
13. Cowland JB, Hother C, Grønbaek K (2007) MicroRNAs and cancer. APMIS 115:1090-106
14. Croce CM (2009) Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 10:704-14
15. Gao P, Tchernyshyov I, Chang TC et al. (2009) C-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 458:762-5
16. Gentleman RC, Carey VJ, Bates DM et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5:R80
17. Hassler MR, Klisaroska A, Kollmann K et al. (2012) Antineoplastic activity of the DNA methyltransferase inhibitor 5-aza-2′-deoxycytidine in anaplastic large cell lymphoma. Biochimie 94:2297-307
18. Imam JS, Plyler JR, Bansal H et al. (2012) Genomic loss of tumor suppressor miRNA-204 promotes cancer cell migration and invasion by activating AKT/mTOR/Rac1 signaling and actin reorganization. PLoS One 7:e52397
19. Ito M, Teshima K, Ikeda S et al. (2014) MicroRNA-150 inhibits tumor invasion and metastasis by targeting the chemokine receptor CCR6, in advanced cutaneous T-cell lymphoma. Blood 123:1499-511
20. Jardin F, Figeac M (2013) MicroRNAs in lymphoma, from diagnosis to targeted therapy. Curr Opin Oncol 25:480-6
21. Kamstrup MR, Gjerdrum LM, Biskup E et al. (2010a) Notch1 as a potential therapeutic target in cutaneous T-cell lymphoma. Blood 116:2504-12
22. Kamstrup MR, Biskup E, Gniadecki R et al. (2010b) Notch signalling in primary cutaneous CD30+ lymphoproliferative disorders: a new therapeutic approach? Br J Dermatol 163:781-8
23. Kempf W, Pfaltz K, Vermeer MH et al. (2011) EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma. Blood 118:4024-35
24. Kent O, Mendell J (2006) A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes. Oncogene 25:6188-96
25. Kopp KL, Ralfkiaer U, Nielsen BS et al. (2013a) Expression of miR-155 and miR-126 in situ in cutaneous T cell lymphoma (CTCL). APMIS 121:1020-4
26. Kopp KL, Ralfkiaer U, Gjerdrum LM et al. (2013b) STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma. Cell Cycle 12:1939-47
27. Laharanne E, Oumouhou N, Bonnet F et al. (2010) Genome-wide analysis of cutaneous T-cell lymphomas identifies three clinically relevant classes. J Invest Dermatol 130:1707-18
28. Lawrie CH (2008) MicroRNA expression in lymphoid malignancies: new hope for diagnosis and therapy? J Cell Mol Med 12:1432-44
29. Lawrie CH (2013) MicroRNAs and lymphomagenesis: a functional review. Br J Haematol 160:571-81
30. Li X, Xu F, Chang C et al. (2013a) Transcriptional regulation of miR-10a/b by TWIST-1 in myelodysplastic syndromes. Haematologica 98:414-9
31. Li B, Sun M, Gao F et al. (2013b) Up-regulated expression of miR-23a/b targeted the pro-apoptotic Fas in radiation-induced thymic lymphoma. Cell Physiol Biochem 32:1729-40
32. Li Y, Gao L, Luo X et al. (2013c) Epigenetic silencing of microRNA-193a contributes to leukemogenesis in t(8;21) acute myeloid leukemia by activating the PTEN/PI3K signal pathway. Blood 121:499-509
33. Li Z, Lei H, Luo M et al. (2014a) DNA methylation downregulated mir-10b acts as a tumor suppressor in gastric cancer. Gastric Cancer; e-pub ahead of print 31 January 2014; doi:10.1007/s10120-014-0340-8
34. Li L, Tang J, Zhang B et al. (2014b) Epigenetic modification of MiR-429 promotes liver tumour-initiating cell properties by targeting Rb binding protein 4. Gut; e-pub ahead of print 26 February 2014; doi:10.1136/gutjnl-2013-305715
35. Liu C, Iqbal J, Teruya-Feldstein J et al. (2013) MicroRNA expression profiling identifies molecular signatures associated with anaplastic large cell lymphoma. Blood 122:2083-92
36. Lopez-Serra P, Esteller M (2012) DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer. Oncogene 31:1609-22
37. Lu J, Getz G, Miska EA et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435:834-8
38. Lujambio A, Calin GA, Villanueva A et al. (2008) A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci USA 105:13556-61
39. Maj J, Jankowska-Konsur A, Sadakierska-Chudy A et al. (2012) Altered microRNA expression in mycosis fungoides. Br J Dermatol 166:331-6
40. Manfè V, Biskup E, Rosbjerg A et al. (2012) miR-122 regulates p53/Akt signalling and the chemotherapy-induced apoptosis in cutaneous T-cell lymphoma. PLoS One 7:e29541
41. Manfè V, Biskup E, Willumsgaard A et al. (2013) cMyc/miR-125b-5p signalling determines sensitivity to bortezomib in preclinical model of cutaneous T-cell lymphomas. PLoS One 8:e59390
42. Marstrand T, Ahler CB, Ralfkiaer U et al. (2014) Validation of a diagnostic microRNA classifier in cutaneous T-cell lymphomas. Leuk Lymphoma 55:957-8
43. McGirt LY, Adams CM, Baerenwald DA et al. (2014) miR-223 regulates cell growth and targets proto-oncogenes in mycosis fungoides/cutaneous T-cell lymphoma. J Invest Dermatol 134:1101-7
44. Moyal L, Barzilai A, Gorovitz B et al. (2013) miR-155 is involved in tumor progression of mycosis fungoides. Exp Dermatol 22:431-3
45. Neves R, Scheel C, Weinhold S et al. (2010) Role of DNA methylation in miR-200c/141 cluster silencing in invasive breast cancer cells. BMC Res Notes 3:219
46. O Connell R, Rao D, Chaudhuri A et al. (2010) Physiological and pathological roles for microRNAS in the immune system. Nat Rev Immunol 10:11-22
47. Persson JL (2013) miRNA in mycosis fungoides and skin inflammation. APMIS 121:1017-9
48. Quintavalle C, Mangani D, Roscigno G et al. (2013) MiR-221/222 target the DNA methyltransferase MGMT in glioma cells. PLoS One 8:e74466
49. Ralfkiaer U, Hagedorn PH, Bangsgaard N et al. (2011) Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL). Blood 118:5891-900
50. Rauhala HE, Jalava SE, Isotalo J et al. (2010) miR-193b is an epigenetically regulated putative tumor suppressor in prostate cancer. Int J Cancer 127:1363-72
51. Sacconi A, Biagioni F, Canu V et al. (2012) miR-204 targets Bcl-2 expression and enhances responsiveness of gastric cancer. Cell Death Dis 3:e423
52. Saito Y, Suzuki H, Tsugawa H et al. (2012) Overexpression of miR-142-5p and miR-155 in gastric mucosa-associated lymphoid tissue (MALT) lymphoma resistant to Helicobacter pylori eradication. PLoS One 7:e47396
53. Salgado R, Servitje O, Gallardo F et al. (2010) Oligonucleotide array-CGH identifies genomic subgroups and prognostic markers for tumor stage mycosis fungoides. J Invest Dermatol 130:1126-35
54. Sanchez-Mut JV, Aso E, Panayotis N et al. (2013) DNA methylation map of mouse and human brain identifies target genes in Alzheimer's disease. Brain 136:3018-27
55. Sánchez-Schmidt JM, Salgado R, Servitje O et al. (2011) Primary cutaneous CD30+ anaplastic large-cell lymphomas show a heterogeneous genomic profile: an oligonucleotide arrayCGH approach. J Invest Dermatol 131:269-71
56. Sandoval J, Heyn H, Moran S et al. (2011) Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome. Epigenetics 6:692-702
57. Sandoval J, Esteller M (2012) Cancer epigenomics: beyond genomics. Curr Opin Genet Dev 22:50-5
58. Sandoval J, Mendez-Gonzalez J, Nadal E et al. (2013) A prognostic DNA methylation signature for stage I non-small-cell lung cancer. J Clin Oncol 31:4140-7
59. Schneider MR (2012) microRNAs as novel players in skin development, homeostasis and disease. Br J Dermatol 166:22-8
60. Smyth GK. (2004) linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3:Article3
61. Sonkoly E, Janson P, Majuri ML et al. (2010) MiR-155 is overexpressed in patients with atopic dermatitis and modulates T-cell proliferative responses by targeting cytotoxic T lymphocyte-associated antigen 4. J Allergy Clin Immunol 126:581-9
62. Swerdlow SH, Campo E, Harris NL et al. (2008) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. WHO Press: Geneva, Switzerland
63. Szuhai K, van Doorn R, Tensen CP et al. (2013) Array-CGH analysis of cutaneous anaplastic large cell lymphoma. Methods Mol Biol 973:197-212
64. van Doorn R, van Kester MS, Dijkman R et al. (2009) Oncogenomic analysis of mycosis fungoides reveals major differences with Sezary syndrome. Blood 113:127-36
65. van Kester MS, Ballabio E, Benner MF et al. (2011) miRNA expression profiling of mycosis fungoides. Mol Oncol 5:273-80
66. van Kester MS, Tensen CP, Vermeer MH et al. (2010) Cutaneous anaplastic large cell lymphoma and peripheral T-cell lymphoma NOS show distinct chromosomal alterations and differential expression of chemokine receptors and apoptosis regulators. J Invest Dermatol 130:563-75
67. Vlachos S, Kostoulas N, Vergoulis T et al. (2012) DIANA miRPath v.2.0: investigating the combinatorial effect of microRNAs in pathways. Nucleic Acids Res 40(Web Server issue):W498-504
68. Vrba L, Jensen TJ, Garbe JC et al. (2010) Role for DNA methylation in the regulation of miR-200c and miR-141 expression in normal and cancer cells. PLoS One 5:e8697
69. Vrba L, Garbe JC, Stampfer MR et al. (2011) Epigenetic regulation of normal human mammary cell type-specific miRNAs. Genome Res 21:2026-37
70. Wang Z, Li Y, Kong D et al. (2010) Crosstalk between miRNA and Notch signaling pathways in tumor development and progression. Cancer Lett 292:141-8
71. Willemze R, Jaffe ES, Burg G et al. (2005) WHO-EORTC classification for cutaneous lymphomas. Blood 105:3768-85
72. Wong HK. (2013) Novel biomarkers, dysregulated epigenetics, and therapy in cutaneous T-cell lymphoma. Discov Med 16:71-8